News for MedAdvisor Limited (MDR.AX)

Published at

Mar 3, 2025 5:17 AM

by gurufocus.com

neutral

neutral

Half Year 2025 MedAdvisor Ltd Earnings Presentation Transcript

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NMDR.AX - Medadvisor LtdHalf Year 2025 MedAdvisor Ltd Earnings PresentationFeb 27, 2025 / 11:30

MDR.AX

Read more →
Published at

May 22, 2024 6:43 AM

by smallcaps.com.au

positive

positive

MedAdvisor Solutions forecasts continued growth for FY25 after stellar year

MedAdvisor Solutions (ASX: MDR) is forecasting further strong growth over the next 12 months after achieving robust recent performances in sales and

MDR.AX

Read more →
Published at

Apr 23, 2024 8:52 AM

by themarketherald.com.au

mixed

mixed

Market Close: ASX drives uphill on continued recovery

The ASX200 closed .4 of a per cent up with IT and Health Care the locomotives of a sluggish steam energy labouring under the weight of Energy and Industrials.

SHV.AX NST.AX MDR.AX PLT.AX PAA.AX

Read more →
Published at

Mar 29, 2024 3:44 PM

by gurufocus.com

positive

positive

Full Year 2023 Medadvisor Ltd Earnings Call Transcript

Sep 07, 2023 / 12:00AM GMTJane Lowe - MedAdvisor Ltd. - IR Well, hello, everyone, and welcome to MedAdvisor's FY23 results webinar. My name's Jane Lowe, I'm the

MDR.AX

Read more →
Published at

Mar 29, 2024 3:44 PM

by gurufocus.com

positive

positive

Half Year 2023 Medadvisor Ltd Earnings Call Transcript

Mar 01, 2023 / 12:00AM GMTRonn Bechler - Automic Group - IR Good morning, everybody, and welcome to MedAdvisor's first half FY '23 results presentation today. W

MDR.AX

Read more →
Published at

Nov 29, 2023 2:23 PM

by globalbankingandfinance.com

positive

positive

Charac secures £1M investment from world-class medication platform MedAdvisor to drive its International growth

Charac secures £1M investment from world-class medication platform MedAdvisor to drive its International growth Total capital raised by Charac now sits at £3...

MDR.AX

Read more →
Published at

Nov 28, 2023 2:59 AM

by themarketherald.com.au

positive

positive

MedAdvisor invests $1.9m in UK pharmacy app for 7.4pc share

MedAdvisor (ASX:MDR) has announced it will invest nearly $2 million into UK-based pharmacy dispensary app Charac.

MDR.AX

Read more →
Published at

Nov 27, 2023 7:20 AM

by themarketherald.com.au

mixed

mixed

TMH Market Close: ASX200 slumps 0.76pc as real estate drags, IT edges higher

So much for a small rise on the market today. Instead, the ASX200 closed down about three quarters (.76) per cent.

PRU.AX ORR.AX MWY.AX LTR.AX MDR.AX ABY.AX

Read more →
Published at

Oct 12, 2023 3:27 PM

by prweb.com

positive

positive

MedAdvisor Solutions THRiV PLATFORM NAMED PM360 TRAILBLAZER AWARD 2023 SILVER WINNER FOR PERSISTENCE/ADHERENCE

/PRNewswire-PRWeb/ -- PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries,...

MDR.AX

Read more →
Published at

Apr 30, 2023 7:20 PM

by stockhead.com.au

mixed

mixed

Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m+ quarterly sales

The healthcare sector is ripe for disruption and artificial intelligence will play a big part in future drug discovery.

PSQ.AX PGC.AX OSX.AX OPT.AX OPT NOXOF NOX.AX IUGNF IMU.AX GSS.AX CYP.AX CKDXF BPH.AX ATX.AX 4DX.AX ZNO.AX SCU.AX RSH.AX PXSLY PXS.AX PAB.AX OCC.AX NC6.AX KZA.AX KMLXF IHL.AX IDT.AX FDMDF DVL.AX CMP.AX BITRF BIT.AX ARUXF AMT.AX ACR.AX 1AD.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX RNO.AX RHY.AX RHT.AX RGS.AX RAC.AX PYC.AX PNV.AX PCK.AX PBP.AX OVN.AX OSL.AX ONE.AX OIL.AX NYR.AX NXSCF NXS.AX MXC.AX MX1.AX MVF.AX MEM.AX MEB.AX MDR.AX MDC.AX MDBIF LBT.AX IVX.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX ICR.AX HCT.AX GTG.AX GLH.AX EYE.AX DXB.AX CSL.AX CPH.AX CGS.AX CAN.AX CALZF CAJ.AX BXN.AX BWXXF BWX.AX BNOEF BNO.AX AT1.AX ARX.AX AMDHF ALC.AX ADR.AX ADO.AX 1ST.AX

Read more →
Published at

Apr 17, 2023 6:50 PM

by stockhead.com.au

mixed

mixed

Dr Boreham’s Crucible: Are MedAdvisor’s US plans about to go to script?

We last covered MedAdvisor in December 2019, when CEO Robert Read expected the US to be the company’s biggest business within five years.

OPRX MDR.AX SYNH

Read more →
Published at

Feb 24, 2023 12:39 AM

by stockhead.com.au

mixed

mixed

Top 10 at 10: Which ASX stocks are flying and floundering on Friday?

Resource Base (ASX:RBX) has the option to acquire the Wali and Ernst Lake lithium projects in the James Bay district of Quebec.

RIE.AX MEB.AX MDR.AX MDBIF MCT.AX LCL.AX 8IH.AX CGS.AX CAV.AX AUH.AX AQX.AX ROG.AX RBX.AX

Read more →
Published at

Feb 1, 2023 5:46 PM

by stockhead.com.au

mixed

mixed

Check Up: The FDA refuses to give CBD a green light, but market doesn’t seem to care

The FDA declined regulate CBD-based supplements and food citing safety reasons, but the CBD index keeps going up.

PYC.AX PSQ.AX PGC.AX MSB.AX KZA.AX EYE.AX DVL.AX CAN.AX BXN.AX BNOEF BNO.AX ADO.AX SOMNF SOM.AX RSH.AX RHT.AX RGS.AX OSX.AX OSL.AX ONE.AX OIL.AX NXSCF NXS.AX MEB.AX MDC.AX MDBIF KMLXF IVX.AX IUGNF IMU.AX IDT.AX GLH.AX CYP.AX CMP.AX CAJ.AX AT1.AX ADR.AX 1ST.AX ZNO.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SCU.AX RNO.AX RHY.AX RAC.AX PXSLY PXS.AX PNV.AX PCK.AX PBP.AX PAB.AX OVN.AX OPT.AX OPT OCC.AX NYR.AX NOXOF NOX.AX NC6.AX MXC.AX MX1.AX MVF.AX MEM.AX MDR.AX LBT.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX IHL.AX ICR.AX HCT.AX GTG.AX GSS.AX FDMDF DXB.AX CPH.AX CKDXF CGS.AX CALZF BWXXF BWX.AX BPH.AX BITRF BIT.AX ATX.AX ARX.AX ARUXF AMT.AX AMDHF ALC.AX ACR.AX 4DX.AX 1AD.AX

Read more →
Published at

Jan 19, 2023 5:50 PM

by stockhead.com.au

mixed

mixed

Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device

Japanese startup OUI Inc says it is on a mission to halve the world's blindness with its smartphone-based device.

ZNO.AX ZLD.AX RAP.AX PSQ.AX PIQ.AX PBP.AX PAA.AX MXC.AX IPDQF IPD.AX IDT.AX GLH.AX CGS.AX BXN.AX 1AD.AX SOMNF SOM.AX SHL.AX RSH.AX RGS.AX PGC.AX PCK.AX OVN.AX OSX.AX OSL.AX OIL.AX NYR.AX NXSCF NXS.AX MX1.AX MDC.AX LBT.AX KZIA KZA.AX KMLXF IVX.AX IMMP IMM.AX IHL.AX GSS.AX FDMDF DVL.AX CYP.AX CPH.AX CAN.AX BWXXF BWX.AX BPH.AX BNOEF BNO.AX BITRF BIT.AX AT1.AX ARX.AX AKU.TO AKU ADR.AX 4DX.AX 1ST.AX VTG.AX VLS.AX UBI.AX SCU.AX RNO.AX RHY.AX RHT.AX RAC.AX PYC.AX PXSLY PXS.AX PNV.AX PAB.AX OPT.AX OPT ONE.AX OCC.AX NOXOF NOX.AX NC6.AX MVF.AX MEM.AX MEB.AX MDR.AX MDBIF IUGNF IMU.AX IMRNW IMRN IMC.AX ICR.AX HCT.AX EYE.AX DXB.AX CMP.AX CKDXF CALZF CAJ.AX ATX.AX ARUXF AMT.AX AMDHF ALC.AX ADO.AX ACR.AX

Read more →
Published at

Jan 4, 2023 6:02 PM

by stockhead.com.au

mixed

mixed

Check Up: Moderna posts crazy cancer vaccine results, says melanoma recurrence down by almost half

Moderna’s stock price rose in late December after the company revealed that a vaccine for melanoma showed encouraging results.

TD1.AX RSH.AX PCK.AX MX1.AX KMLXF DVL.AX CAJ.AX BNOEF BNO.AX ARX.AX ADR.AX 1ST.AX ZNO.AX RHY.AX RAC.AX PYC.AX PSQ.AX PGC.AX OVN.AX OSX.AX ONE.AX OCC.AX NOXOF NOX.AX NC6.AX MDC.AX KZA.AX IPDQF IPD.AX IDT.AX GTG.AX CYP.AX CPH.AX CAN.AX BXN.AX BWXXF BWX.AX BPH.AX BITRF BIT.AX ATX.AX ZLD.AX VTG.AX VLS.AX UBI.AX SOMNF SOM.AX SCU.AX RNO.AX RHT.AX RGS.AX PXSLY PXS.AX PNV.AX PBP.AX PAB.AX OSL.AX OPT.AX OPT OIL.AX NYR.AX NXSCF NXS.AX MXC.AX MVF.AX MEM.AX MDR.AX LBT.AX IVX.AX IUGNF IMU.AX IMRNW IMRN IMM.AX IMC.AX IHL.AX ICR.AX HCT.AX GSS.AX GLH.AX FDMDF EYE.AX DXB.AX CMP.AX CKDXF CGS.AX CALZF AT1.AX ARUXF AMT.AX AMDHF ALC.AX ADO.AX ACR.AX 4DX.AX 1AD.AX

Read more →
Published at

Jan 3, 2023 8:41 PM

by stockhead.com.au

mixed

mixed

ASX December Winners: Who’s led the way for small caps in tough month for global markets?

Global share markets and the ASX fell in December to end what has been a volatile 2022 with economic and geopolitical concerns.

ZIZTF VTMXF VML.AX TTM.AX TOEYF TOE.AX SZL.AX SEZNL SDV.AX RSG.AX RMY.AX RED.AX PCL.AX NVX.AX NVNXF NGY.AX MYX.AX MTLS MME.AX MLXEF MLX.AX MKR.AX MAY.AX LME.AX LIN.AX LCL.AX INR.AX GTK.AX GSCCF G1A.AX CKA.AX CBE.AX BNOEF BNO.AX AVA.AX 3DA.AX ZOEFF TNT.AX SVY.AX STX.AX SOR.AX RFX.AX REFXF PBH.AX MTC.AX MRM.AX MDR.AX MCM.AX GLN.AX BOC.AX BBX.AX ABY.AX YOJ.AX WGO.AX TIG.AX SOP.AX RFG.AX MRL.AX MFD.AX MEI.AX IMMP IMM.AX IHL.AX GNX.AX FRDSF ERD.NZ ERD.AX EPY.AX EOFBF EOF.AX EGR.AX DCN.AX CRR.AX CAI.AX BTH.AX BNL.AX ARL.AX AMI.AX 4DS.AX

Read more →
Published at

Dec 2, 2022 6:58 AM

by stockhead.com.au

mixed

mixed

Weekly Small Cap and IPO wrap: Small caps up 0.55% for week tracking broader index

The S&P/ASX Emerging Companies (XEC) indices has finished the week up 0.55% and in a further positive sign is up 4.84% in past month.

ZOEFF WKT.AX WFL.AX VIP.AX SHL.AX NAE.AX MIN.AX MDR.AX KNM.AX KNEOF GTK.AX FRDSF FAU.AX DXN.AX CFO.AX CFFMF CBR.AX BRY BPH.AX 4DS.AX WGO.AX WEC.AX SVY.AX SKN.AX MTR.AX MOB.AX LIN.AX LCL.AX KFE.AX KEY.AX IVZ.AX ICNOF ICN.AX HMX.AX HLX.AX E2M.AX DEV.AX CSE.AX CLE.AX AUK.AX ARV.AX AQD.AX AJL.AX WBE.AX THR.L THR.AX THORF TASEF TAS.AX MTH.AX MRQ.AX M8S.AX LVTSF LVT.AX ICG.AX ICE.AX HAW.AX EML.AX CKF.AX CBE.AX ASP.AX ARN.AX AR9.AX AQX.AX 99L.AX

Read more →
Published at

Nov 30, 2022 8:10 PM

by stockhead.com.au

mixed

mixed

Check Up: The world's most expensive drug costs $3.5 MILLION a shot

The US FDA has just approved the world’s most expensive drug. CSL Behring’s hemophilia B gene therapy costs US$3.5m a dose.

PAB.AX OCC.AX NC6.AX MDR.AX IMM.AX GTG.AX GSS.AX EYE.AX CSLN.MX CSLLY CSL.AX CMXHF BPH.AX SHL.AX RAC.AX PSQ.AX ONE.AX NYR.AX NXSCF NXS.AX MXC.AX KZA.AX FDMDF DXB.AX DVL.AX CYP.AX CPH.AX CGS.AX AT1.AX ARX.AX ARUXF AMDHF ALC.AX ACR.AX 4DX.AX ZNO.AX ZLD.AX VTG.AX VLS.AX UBI.AX TD1.AX SOMNF SOM.AX SCU.AX RSH.AX RNO.AX RHY.AX RHT.AX RGS.AX PYC.AX PXSLY PXS.AX PNV.AX PGC.AX PCK.AX PBP.AX OVN.AX OSX.AX OSL.AX OPT.AX OPT OIL.AX NOXOF NOX.AX MX1.AX MVF.AX MEM.AX MEB.AX MDC.AX MDBIF LBT.AX KMLXF IVX.AX IUGNF IPDQF IPD.AX IMU.AX IMRNW IMRN IMC.AX IHL.AX IDT.AX ICR.AX HCT.AX GLH.AX CMP.AX CKDXF CAN.AX CALZF CAJ.AX BXN.AX BWXXF BWX.AX BNOEF BNO.AX BITRF BIT.AX ATX.AX AMT.AX ADR.AX ADO.AX 1ST.AX 1AD.AX

Read more →
Published at

Nov 25, 2022 6:48 AM

by stockhead.com.au

mixed

mixed

Weekly Small Cap and IPO wrap: Big boys up, but small caps down 0.88% this week

A huge week for local and global markets has ended with the ASX200 up % but the small cap indices down 0.84%.

XTE.AX XF1.AX WZR.AX TLGRF TLG.AX SHV.AX SFG.AX REN.JO PPL.AX PPL POD.AX PEN.AX NXLLF NXL.AX NEW.AX NET.AX NCK.AX MZZ.AX MMMKF MLXEF MLX.AX MKR.AX MFB.AX MDR.AX LME.AX LGL.AX JAL.AX IRI.AX GRV.AX GME.AX EXR.AX ENR.AX EML.AX ELTLF ELT.AX CZR.AX CBRE CBE.AX BSA.AX BKY.AX BBX.AX BAT.AX AU AMI.AX AGG.AX AEI.AX TER.AX S2R.AX NVA.AX MOZ.AX MGV.AX LTR.AX LRS.AX LOT.AX LIFX IVZ.AX FML.AX CKA.AX BRK.AX ARV.AX AGY.AX 360.AX VRC.AX TOEYF TOE.AX SDG.AX LPD.AX IOD.AX GLL.AX EGG.AX 99L.AX

Read more →
Published at

Nov 23, 2022 7:50 PM

by stockhead.com.au

mixed

mixed

How out of favour Biotech has a PR problem and could learn from Dr Karl

ASX health stocks have fallen out of favour in 2022 with a a rotation out of growth into value sectors but could it also do with better PR?

VTG.AX NEU.AX MXC.AX KZA.AX CSL.AX COH.AX BWXXF BWX.AX AT1.AX ADR.AX ADO.AX ZNO.AX ZLD.AX UBI.AX TD1.AX SHL.AX RSH.AX RHT.AX RAC.AX PNV.AX PBP.AX OVN.AX OSX.AX OSL.AX OCC.AX NOXOF NOX.AX MVF.AX MEM.AX MEB.AX MDC.AX MDBIF LBT.AX KMLXF IUGNF IMU.AX ICS.AX ICR.AX EYE.AX CPH.AX CMP.AX CALZF BXN.AX AMDHF 1ST.AX VLS.AX SOMNF SOM.AX SCU.AX RNO.AX RHY.AX RGS.AX PYC.AX PXSLY PXS.AX PSQ.AX PGC.AX PCK.AX PAB.AX OPT.AX OPT ONE.AX OIL.AX NYR.AX NXSCF NXS.AX MX1.AX MDR.AX IVX.AX IPDQF IPD.AX IMRNW IMRN IMM.AX IMC.AX IHL.AX IDT.AX HCT.AX GTG.AX GSS.AX GLH.AX FDMDF DXB.AX DVL.AX CYP.AX CKDXF CGS.AX CAN.AX CAJ.AX BPH.AX BNOEF BNO.AX BITRF BIT.AX ATX.AX ARX.AX ARUXF AMT.AX ALC.AX ACR.AX 4DX.AX 1AD.AX

Read more →